Revenue growth momentum intact (outperforming peers) despite weak macros.

Jyothy Labs Q2 Results Review - Superior Execution Trumps Unconducive Macros: ICICI Securities

Arrives at a target price of Rs 440/share, which implies an upside of 20% from the current market price.

Jyothy Labs - Embracing Transformation For Long-Term Growth: Yes Securities Initiates Coverage With A ‘Buy’

Sharekhan is bullish on Jyothy Labs has recommended buy rating on the stock with a target price of Rs 375 in its research report dated August 24, 2023.

Buy Jyothy Labs; target of Rs 375: Sharekhan

MR Jyothy, in her first-ever interview as MD of Jyothy Labs, talks about the future & legacy of the company in a candid conversation with Mangalam Maloo. Listen in 

#weekender #jyothylabs #businessnews #candidconversation #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
                               👑 Check Out Top CNBC TV18 Playlist Videos: 

🔹CNBC TV18 Classic Interviews: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDmfXVg7XEQngsCY9RoS-fv

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDCcaVZ_82M9vhLo9lGJYzo

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH
🔹CNBC TV18 Newsreels: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCmABWWQRX4NqGLCtScwqex

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Starup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

MD Of Jyothy Labs On Future & Legacy Of The Company | MR Jyothy | N18V | CNBC TV18

Jyothy Labs’ stock has surged on the back of an impressive Q1 performance, with a 700-basis points rise in operating margins and profits doubling year-on-year. This success is attributed to increased volumes, lower input costs, and a strategic focus on premiumization and market penetration through l…

Jyothy Labs: Robust Q1 Performance and Strategic Growth in FMCG Sector

Indian indices BSE Sensex and Nifty experienced a slight decline after four weeks of gains, amid US Fed’s expected rate hikes. BSE Power, BSE Realty, and BSE Healthcare were top-performing sectors, while BSE Oil and Gas, BSE FMCG, and BSE Bankex ended lower. Godfrey Phillips, Jyothy Labs, and REC e…

Three stocks that outperformed in the week ending July 28

Sharekhan is bullish on Jyothy Labs has recommended buy rating on the stock with a target price of Rs 340 in its research report dated July 25, 2023.

Buy Jyothy Labs; target of Rs 340: Sharekhan

ICICI Securities is bullish on Jyothy Labs recommended buy rating on the stock with a target price of Rs 340 in its research report dated July 26, 2023.

Buy Jyothy Labs; target of Rs 340: ICICI Securities

Jyothy Labs saw a 100% increase in net profit to ₹96 crore in Q1 FY24, up from ₹48 crore in the same period last year. Revenue from operations rose 15.07% YoY to ₹687 crore. Fabric care, dishwashing, household insecticides and personal care sales all increased. MD Jyothy said the company is focused …

Jyothy Labs’ net profit soars by 100%, sales rise by 15%

Sharekhan maintains a Buy recommendation on the stock with a revised price target of Rs 340.

Jyothy Labs shares hit 52-week high on strong Q1 numbers; Sharekhan keeps ‘Buy’

The EBITDA margin for the quarter stood at 17.1 percent versus 10 percent at same period last year, thereby an increase of 96.3 percent.

Jyothy Labs Net Sales Grows By 15.1% at ₹687 Cr In Q1FY24

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Jyothy Laboratories Limited is a multi-brand, multi-product FMCG company. It is principally engaged in manufacturing and marketing of fabric whiteners, soaps, detergents, mosquito repellents, scrubber, bodycare and incense sticks.

Jyothy Labs Ltd